Rigel Pharmaceuticals announced a management transition: Lisa Rojkjaer retired as Chief Medical Officer effective July 1, 2026, and Alison Hannah was appointed as the new CMO the same day. The update is operational and does not provide any guidance or financial impact details.
Rigel Pharmaceuticals announced a management transition: Lisa Rojkjaer retired as Chief Medical Officer effective July 1, 2026, and Alison Hannah was appointed as the new CMO the same day. The update is operational and does not provide any guidance or financial impact details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
